v3.26.1
Fair Value Measurements
6 Months Ended
Jun. 30, 2026
Fair Value Measurements [Abstract]  
Fair Value Measurements NOTE 12 – FAIR VALUE MEASUREMENTS

The accounting guidance establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1 – Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date.

Level 2 – Observable inputs such as quoted prices for similar instruments and quoted prices in markets that are not active, and inputs that are directly observable or can be corroborated by observable market data. The types of assets and liabilities included in Level 2 are typically either comparable to actively traded securities or contracts, such as treasury securities with pricing interpolated from recent trades of similar securities, or priced with models using highly observable inputs, such as commodity options priced using observable forward prices and volatilities.

Level 3 – Significant inputs to pricing that have little or no observability as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as the complex and subjective models and forecasts used to determine the fair value of financial instruments.

Financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025 are summarized below.

June 30, 2026

Level 1

Level 2

Level 3

Total Fair Value

Cash equivalents:

Money market funds

$

675,258

$

$

$

675,258

Total

$

675,258

$

$

$

675,258

December 31, 2025

Level 1

Level 2

Level 3

Total Fair Value

Cash equivalents:

Money market funds

$

665,582

$

$

$

665,582

Total

$

665,582

$

$

$

665,582

The following tables present reconciliations of recurring fair value measurements that use significant unobservable inputs (Level 3):

Three Months Ended June 30, 2025

Contingent value rights

Warrant liability

Contingent forward contract

Total

March 31, 2025

$

(292,901)

$

$

(5,406,033)

$

(5,698,934)

Additions

(9,399,054)

(9,399,054)

Warrant exercise

16,662,707

16,662,707

Fair value adjustments

6,271

(7,531,044)

789,588

(6,735,185)

Settlement

267,391

4,616,445

4,883,836

June 30, 2025

$

(286,630)

$

$

$

(286,630)

Six Months Ended June 30, 2025

Contingent value rights

Warrant liability

Embedded derivative liability

Contingent forward contract

Total

December 31, 2024

$

(312,080)

$

$

(82,281)

$

$

(394,361)

Additions

(9,399,054)

(5,515,525)

(14,914,579)

Extinguishment of debt

82,281

82,281

Warrant exercise

16,662,707

16,662,707

Fair value adjustments

25,450

(7,531,044)

899,080

(6,606,514)

Settlement

267,391

4,616,445

4,883,836

June 30, 2025

$

(286,630)

$

$

$

$

(286,630)

The estimated fair value of the Contingent Value Rights (“CVR”) as of June 30, 2026 and December 31, 2025 was $0, respectively. The Company recorded a $25,450 gain on the fair value remeasurement of the CVRs during the six months ended June 30, 2025.

The estimated fair value of the contingent forward contract was $0 as of June 30, 2026 and December 31, 2025, respectively. The estimated fair value was considered a Level 3 measurement and the fair value of the contingent forward contract is determined using a Monte Carlo simulation. As a result of the fair value remeasurement, the Company

recorded a remeasurement gain of $789,588 and $899,080 in the three and six months ended June 30, 2025, respectively. See Note 9, Equity, for further information.

The fair value remeasurements noted above were recorded within other (expense) income in the condensed consolidated statements of operations.

We record transfers between levels of the fair value hierarchy, if necessary, at the end of the reporting period. There were no transfers between levels during the six months ended June 30, 2026.